FDA panel recommends dropping serious warning on Pfizer's Chantix

(Reuters) - A serious warning on Pfizer Inc's drug that helps quit smoking should be removed, 10 of 19 independent panelists to the U.S. Food and Drug Administration recommended on Wednesday, after reviewing additional trial data.

FDA panel recommends dropping serious warning on Pfizer's Chantix
Read More


Bagikan Berita Ini